Augmedix Inc.

NASDAQ: AUGX · Real-Time Price · USD
2.35
0.00 (0.00%)
At close: Oct 01, 2024, 9:57 PM

Augmedix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
44.85M 30.93M 22.16M
Cost of Revenue
23.33M 16.98M 12.16M
Gross Profit
21.53M 13.95M 10.01M
Operating Income
-18.78M -22.37M -17.94M
Interest Income
1.11M 245K 15K
Pretax Income
-19.03M -24.45M -17.85M
Net Income
-19.17M -26.53M -17.16M
Selling & General & Admin
29.13M 26.18M 21.27M
Research & Development
11.18M 10.15M 6.68M
Other Expenses
n/a n/a 87K
Operating Expenses
40.3M 36.33M 27.95M
Interest Expense
2.25M 1.68M 2.25M
Selling & Marketing Expenses
10.69M 9.28M 7.51M
Cost & Expenses
63.63M 53.3M 40.1M
Income Tax Expense
145K 2.08M -691K
Shares Outstanding (Basic)
43.95M 37.42M 28.91M
Shares Outstanding (Diluted)
43.95M 37.42M 28.91M
EPS (Basic)
-0.44 -0.71 -0.59
EPS (Diluted)
-0.44 -0.71 -0.59
EBITDA
-17.68M -21.81M -14.47M
EBIT
-16.77M -22.66M -15.16M
Depreciation & Amortization
1.1M 1.53M 691K